-
Mashup Score: 0FDA REMS Program Shows Promising Results for Mavacamten in Hypertrophic Cardiomyopathy Treatment - 9 hour(s) ago
Milind Desai, MD, MBA shares insight into the REMS program for patients with obstructive hypertrophic cardiomyopathy.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0AHA 2024: Providing Feedback for Pharmacists Improved Care for Veterans With Heart Failure - 9 hour(s) ago
Within the Veterans Health Administration System, primary care pharmacists are embedded in primary care panels and work alongside primary care physicians and nurses to optimize medication management for patients.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
Findings from the PHARMA-HF demonstrate that #pharmacists who received feedback on heart failure medication rates, in addition to educational tools, increased the frequency at which they managed HF and adjusted these medications. https://t.co/KUvASSMd43
-
-
Mashup Score: 3
Improving collaboration and communication between all members of the health care team is one way to address these challenges.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
In a discussion-based session, experts reviewed challenges and opportunities to improve #lipid-lowering medication adherence, including clinician hesitancy. Pharmacists can play a vital role, they said. https://t.co/gbIDhZF18o
-
-
Mashup Score: 8AHA 2024: Tirzepatide Lowers Risk of Worsening Heart Failure, CVD Death in Adults With Obesity - 9 hour(s) ago
This is the first trial that tested the effect of any medication on major heart failure outcomes in patients with HFpEF and obesity, according to investigators.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
New #breaking findings from #AHA24 show tirzepatide lowers risk of worsening heart failure and cardiovascular death in adults with #obesity. Learn more: https://t.co/iIYw2cEFrs
-
-
Mashup Score: 1AHA 2024: Tirzepatide Lowers Risk of Worsening Heart Failure, CVD Death in Adults With Obesity - 14 hour(s) ago
This is the first trial that tested the effect of any medication on major heart failure outcomes in patients with HFpEF and obesity, according to investigators.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
New #breaking findings from #AHA24 show tirzepatide lowers risk of worsening heart failure and cardiovascular death in adults with #obesity. Learn more: https://t.co/iIYw2cEFrs
-
-
Mashup Score: 1Study Shows Shingles Infection Could Be Associated With Dementia - 16 hour(s) ago
Use of antitherapeutic medication prescribed for herpes zoster related to lower risk of subsequent dementia.
Source: www.pharmacytimes.comCategories: General Medicine News, PayerTweet-
#Shingles infection was not significantly associated with increased #dementia risk in the overall population, but anti-herpetic medication's linkage to reduced dementia risk in certain subgroups indicates a possibly deeper association. Read more: https://t.co/l3Dnw1eyX9
-
-
Mashup Score: 2AHA 2024: Patients With Cardiovascular Conditions Want More Guidance About Sexual Health - 1 day(s) ago
Community pharmacists are playing an increasing role in sexual and reproductive health services and can provide that trustworthy information to patients.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
Research being presented at the American Heart Association 2024 Scientific Sessions found that patients with #cardiovascular conditions want more guidance on sexual health from their care team. Read more, and follow our AHA coverage: https://t.co/irDzsycBMM
-
-
Mashup Score: 1
The indication is for adult and pediatric patients 1 year and older with a lysine methyltransferase 2A gene translocation.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
Breaking News: The #FDA has approved revumenib for relapsed or refractory acute #leukemia with KMT2A translocation in adult and pediatric patients aged 1 year and older. Coverage is ongoing: https://t.co/7s8NkPQz4l
-
-
Mashup Score: 2
The label includes postmarking reports showing rare instances of pulmonary aspiration for patients undergoing procedures that require general anesthesia or deep sedation.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
The #FDA has added a new label for semaglutide that refers to the possibility of delayed gastric emptying, including postmarking reports of rare instances of pulmonary aspiration for patients receiving #GLP-1 receptor agonists. Learn more: https://t.co/PqQVhBHtZx
-
-
Mashup Score: 1Insights on Innovation: Craig Beavers Previews AHA 2024 and Emerging Trends in Cardiovascular Care - 2 day(s) ago
Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP will be moderating a session about social determinants of health and heart failure.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
Clinical pharmacist Craig Beavers provides a preview of the data set to be presented at the #AHA Scientific Sessions in Chicago, and highlights emerging trends in cardiovascular care that will be discussed by key figures in the field. Watch the interview: https://t.co/XEZAyWc9wg
-
In an exclusive interview, Milind Desai, MD, MBA, shared insight into the #REMS program for patients with obstructive hypertrophic #cardiomyopathy. https://t.co/NVzCctCkBQ